Artelo Biosciences reports ART27.13 weight reduction in mice
Company says ART27.13 cut body weight by ~20% as monotherapy and ~40% with semaglutide in a nonclinical diet-induced obesity mouse model.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Company says ART27.13 cut body weight by ~20% as monotherapy and ~40% with semaglutide in a nonclinical diet-induced obesity mouse model.